涨超5%，司美格鲁肽片剂上市首日开出3071张处方

华创新药01-17

诺和诺德周五发布消息称，该公司本月早些时候推出的口服司美格鲁肽片在商业推广的前4天就获得了3071张美国处方。据巴克莱分析师的报告，实际的处方数量将会更高，因为这些数据只包含了这种每日服用一次的口服GLP-1激动剂的零售处方，不包括通过诺和诺德直营平台诺和药房提交的处方。该公司于1月5日以每月149美元的价格向现金支付的客户推出了这款产品，随后，亚马逊等零售商也加入了推广队伍。去年12月美国批准了...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2604990348?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-17 00:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2604990348","market":"us","top_or_hot":-1,"title":"涨超5%，司美格鲁肽片剂上市首日开出3071张处方","media":"华创新药","content":"<div>\n<p>诺和诺德周五发布消息称，该公司本月早些时候推出的口服司美格鲁肽片在商业推广的前4天就获得了3071张美国处方。据巴克莱分析师的报告，实际的处方数量将会更高，因为这些数据只包含了这种每日服用一次的口服GLP-1激动剂的零售处方，不包括通过诺和诺德直营平台诺和药房提交的处方。该公司于1月5日以每月149美元的价格向现金支付的客户推出了这款产品，随后，亚马逊等零售商也加入了推广队伍。去年12月美国批准了...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117000926a723a43b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>涨超5%，司美格鲁肽片剂上市首日开出3071张处方</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n涨超5%，司美格鲁肽片剂上市首日开出3071张处方\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-17 00:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117000926a723a43b&s=b><strong>华创新药</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>诺和诺德周五发布消息称，该公司本月早些时候推出的口服司美格鲁肽片在商业推广的前4天就获得了3071张美国处方。据巴克莱分析师的报告，实际的处方数量将会更高，因为这些数据只包含了这种每日服用一次的口服GLP-1激动剂的零售处方，不包括通过诺和诺德直营平台诺和药房提交的处方。该公司于1月5日以每月149美元的价格向现金支付的客户推出了这款产品，随后，亚马逊等零售商也加入了推广队伍。去年12月美国批准了...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117000926a723a43b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117000926a723a43b&s=b","article_id":"2604990348","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117000926a723a43b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2604990348","pubTimestamp":1768579560,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"诺和诺德周五发布消息称，该公司本月早些时候推出的口服司美格鲁肽片在商业推广的前4天就获得了3071张美国处方。去年12月美国批准了这种药片，使其成为首个获得许可用于治疗肥胖症的口服GLP-1药物，巴克莱的数据显示了这家丹麦制药商在有前景的口服肥胖药物市场巩固其先发优势的初步迹象。根据路透社看到的内部文件，美国食品和药物管理局正对礼来公司生产的口服减肥药进行优先审查，预计将于4月10日做出决定。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","BK4532":"文艺复兴科技持仓","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","NVO":"诺和诺德","BK4007":"制药","BK4599":"减肥药"},"translate_title":"Up more than 5%, 3,071 prescriptions were issued for semaglutide tablets on the first day of listing","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1.95},"content_text":"诺和诺德周五发布消息称，该公司本月早些时候推出的口服司美格鲁肽片在商业推广的前4天就获得了3071张美国处方。据巴克莱分析师的报告，实际的处方数量将会更高，因为这些数据只包含了这种每日服用一次的口服GLP-1激动剂的零售处方，不包括通过诺和诺德直营平台诺和药房提交的处方。该公司于1月5日以每月149美元的价格向现金支付的客户推出了这款产品，随后，亚马逊等零售商也加入了推广队伍。去年12月美国批准了这种药片，使其成为首个获得许可用于治疗肥胖症的口服GLP-1药物，巴克莱的数据显示了这家丹麦制药商在有前景的口服肥胖药物市场巩固其先发优势的初步迹象。根据路透社看到的内部文件，美国食品和药物管理局正对礼来公司生产的口服减肥药进行优先审查，预计将于4月10日做出决定。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2604990348","isCrawlerRequest":true}